Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
Closing soonR01Clinical trial: Optional / allowed

Alcohol Health Services Research (R01 Clinical Trial Optional)

National Institutes of Health (NIH) · NIH Institute/Center · PA-25-245

Source: Grants.gov · View original posting ↗

Award
Up to $500K
Deadline
Sep 7, 2026
Letter of intent
Mechanism
R01
Duration
Expected awards
Funding cycle
Standard NIH dates
Open date
Nov 27, 2024
Total funding
$500K total
Clinical trial
Optional / allowed
Established investigatorSmall businessGovernmentHigher educationNonprofitForeign entities

Funding context

16%of applications funded

Based on FY2024 NIH (all institutes) R01 applications (5,385 of 33,139 applications awarded).

Institute-specific data wasn’t available — showing the NIH-wide rate for this mechanism.

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIH-wide R01, all institutes.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Research areas

Basic mechanisms & biologyTherapeutics & drug discoveryHealth disparities

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations.

Data notes: administering NIH institute could not be identified from the opportunity number.